This photo shows signage outside the Amgen headquarters in Thousand Oaks, Calif on Nov. 9, 2014. Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics. The Federal Trade Commission said Tuesday, May 16, 2023, that the deal, announced last December, would give Amgen unfair leverage to block competition for Horizon medications. (AP Photo/Mark J. Terrill, File)
Featured Photo Galleries
Trump Transition: Here are the people Trump has picked for key positions so far
President-elect Donald Trump has announced a flurry of picks for his incoming administration. Get full coverage of the Trump transition from The Washingon Times.
Trump dances onstage, takes post-election nation by storm
President-elect Trump dances onstage
